San Diego, CA, United States of America

Justin Chapman

This inventor holds 5 USPTO granted patents and 7 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Sova Pharmaceuticals, Inc., Hepatikos Therapeutics, LLC, Misfolding Diagnostics, Inc.. Active years: 2017-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Justin Chapman. Retrieved from https://idiyas.com/inventor/justin-chapman-8sn2meq2

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 40.0


 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2017-2020

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Innovations by Inventor Justin Chapman in San Diego, CA

Introduction

Justin Chapman is a renowned inventor based in San Diego, California, known for his significant contributions to the field of pharmaceutical sciences. With a portfolio of five patents, Chapman has developed innovative solutions targeting a range of diseases and health disorders, making him a key figure in the medical research community.

Latest Patents

One of Justin Chapman's latest patents involves ASK1 isoindolin-1-one inhibitors. These compounds are aimed at treating various diseases and pathologies linked to the activation of ASK1, encompassing cardiovascular issues, inflammatory disorders (both acute and chronic), autoimmune diseases, destructive bone disorders, fibrotic conditions such as alcoholic steatohepatitis, non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), neurodegenerative disorders, and metabolic diseases including diabetes. Another notable patent concerns cystathionine-gamma-lyase (CSE) inhibitors. This invention comprises compounds and pharmaceutical compositions that inhibit CSE, along with methods for using these inhibitors to treat conditions that could benefit from CSE inhibition.

Career Highlights

Throughout his career, Justin Chapman has made significant strides in pharmaceutical innovation. He has worked with reputable companies, notably Sova Pharmaceuticals, Inc. and Misfolding Diagnostics, Inc., where he leveraged his expertise to drive forward projects that contribute to medical advancements.

Collaborations

In his journey, Justin has collaborated with distinguished professionals in the field, including esteemed coworkers Sergio G Durón and Simon G Sydserff. These partnerships have enriched his research projects, allowing for interdisciplinary approaches to complex medical challenges.

Conclusion

Justin Chapman stands out as an influential inventor in the pharmaceutical realm, with multiple patents that address urgent health issues. His work not only showcases his innovative spirit but also reflects his commitment to improving health outcomes through advanced research and development. As he continues to make strides in his field, the impact of his inventions will resonate within the medical community and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…